COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 202 filers reported holding COHERUS BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $189,000 | +19.6% | 11,775 | +2.8% | 0.00% | – |
| Q2 2021 | $158,000 | -5.4% | 11,450 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $167,000 | -16.1% | 11,450 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $199,000 | -5.2% | 11,450 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $210,000 | +2.4% | 11,450 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $205,000 | +10.8% | 11,450 | -0.7% | 0.00% | 0.0% |
| Q1 2020 | $185,000 | -10.6% | 11,530 | +0.1% | 0.00% | 0.0% |
| Q4 2019 | $207,000 | -21.6% | 11,524 | -11.8% | 0.00% | 0.0% |
| Q3 2019 | $264,000 | -1.5% | 13,068 | +7.3% | 0.00% | -50.0% |
| Q2 2019 | $268,000 | +71.8% | 12,184 | +6.4% | 0.00% | +100.0% |
| Q1 2019 | $156,000 | +50.0% | 11,450 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $104,000 | -39.2% | 11,450 | +10.6% | 0.00% | 0.0% |
| Q3 2018 | $171,000 | +17.9% | 10,350 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $145,000 | +27.2% | 10,350 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $114,000 | – | 10,350 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
| CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
| AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
| Knott David M Jr | 630,000 | $2,356 | 0.90% |
| COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
| Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
| Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
| Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |